BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3780810)

  • 1. Augmented natural killer activity in ovarian cancer patients treated with cimetidine.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1037-43. PubMed ID: 3780810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
    Hirai N; Hill NO; Motoo Y; Osther K
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer.
    Lukomska B; Olszewski WL; Engeset A; Kolstad P
    Cancer; 1983 Feb; 51(3):465-9. PubMed ID: 6401589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
    Flodgren P; Sjögren HO
    Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
    Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
    Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
    Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro.
    Nair MP; Schwartz SA
    Cell Immunol; 1983 Oct; 81(1):45-60. PubMed ID: 6225527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cimetidine on interleukin-2 production by peripheral blood lymphocytes in advanced ovarian carcinoma.
    Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1185-90. PubMed ID: 3138120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
    Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
    Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.
    Yanagawa E; Toge T; Sawamura A; Kegoya Y; Baba N; Hattori T
    Jpn J Surg; 1988 Nov; 18(6):660-7. PubMed ID: 2977625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
    Allavena P; Introna M; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural immunity against ovarian tumors.
    Lotzová E; Savary CA; Freedman R; Bowen JM
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):269-75. PubMed ID: 3491727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
    Lin CY; Bai DJ; Yuan HY; Wang K; Yang GL; Hu MB; Wu ZQ; Li Y
    World J Gastroenterol; 2004 Jan; 10(1):136-42. PubMed ID: 14695785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
    Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
    J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
    Lichtenstein AK; Berek J; Zighelboim J
    J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity and progression-free survival in ovarian cancer.
    Garzetti GG; Cignitti M; Ciavattini A; Fabris N; Romanini C
    Gynecol Obstet Invest; 1993; 35(2):118-20. PubMed ID: 8383627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.